Myelodysplastic Syndrome News

FDA Approves Vyxeos for Adults with Poor Prognosis AML (August 7, 2017)

The U.S. Food and Drug Administration granted regular approval to a liposome-encapsulated combination of daunorubicin and cytarabine for the treatment of adults with newly-diagnosed therapy-related AML (t-AML) or AML with myelodysplasia-related changes... Continue Reading

Latest Myelodysplastic Syndrome News By Stage

General Myelodysplastic Syndrome

Sorry, there are no articles available for this cancer stage.

More General Myelodysplastic Syndrome